Literature DB >> 30112699

Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice.

Abdel A Belaidi1, Adam P Gunn1, Bruce X Wong2, Scott Ayton1, Ambili T Appukuttan1, Blaine R Roberts1, James A Duce1,2, Ashley I Bush3.   

Abstract

Proteolytic cleavage of the amyloid precursor protein (APP) into the Aβ peptide has been an extensively researched mechanism for Alzheimer's disease, but the normal function of the protein is less understood. APP functions to regulate neuronal iron content by stabilizing the surface presentation of ferroportin-the only iron exporter channel of cells. The present study aims to quantify the contribution of APP to brain and peripheral iron by examining the lifetime impact on brain and liver iron levels in APP knockout mice. Consistent with previous reports, we found that wild-type mice exhibited an age-dependent increase in iron and ferritin in the brain, while no age-dependent changes were observed in the liver. APP ablation resulted in an exaggeration of age-dependent iron accumulation in the brain and liver in mice that was assessed at 8, 12, 18, and 22 months of age. Brain ferroportin levels were decreased in APP knockout mice, consistent with a mechanistic role for APP in stabilizing this iron export protein in the brain. Iron elevation in the brain and liver of APP knockout mice correlated with decreased transferrin receptor 1 and increased ferritin protein levels. However, no age-dependent increase in brain ferritin iron saturation was observed in APP-KO mice despite similar protein expression levels potentially explaining the vulnerability of APP-KO mice to parkinsonism and traumatic brain sequelae. Our results support a crucial role of APP in regulating brain and peripheral iron, and show that APP may act to oppose brain iron elevation during aging.

Entities:  

Keywords:  Amyloid precursor protein; Brain; Ferritin; Iron; Neurodegeneration

Mesh:

Substances:

Year:  2018        PMID: 30112699      PMCID: PMC6277293          DOI: 10.1007/s13311-018-0656-x

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  35 in total

1.  In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice.

Authors:  Clifford R Jack; Thomas M Wengenack; Denise A Reyes; Michael Garwood; Geoffrey L Curran; Bret J Borowski; Joseph Lin; Gregory M Preboske; Silvina S Holasek; Gregor Adriany; Joseph F Poduslo
Journal:  J Neurosci       Date:  2005-10-26       Impact factor: 6.167

2.  The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons.

Authors:  Changyi Ji; Brittany L Steimle; Danielle K Bailey; Daniel J Kosman
Journal:  Cell Mol Neurobiol       Date:  2017-11-25       Impact factor: 5.046

3.  beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity.

Authors:  H Zheng; M Jiang; M E Trumbauer; D J Sirinathsinghji; R Hopkins; D W Smith; R P Heavens; G R Dawson; S Boyce; M W Conner; K A Stevens; H H Slunt; S S Sisoda; H Y Chen; L H Van der Ploeg
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

4.  Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline.

Authors:  Scott Ayton; Amir Fazlollahi; Pierrick Bourgeat; Parnesh Raniga; Amanda Ng; Yen Ying Lim; Ibrahima Diouf; Shawna Farquharson; Jurgen Fripp; David Ames; James Doecke; Patricia Desmond; Roger Ordidge; Colin L Masters; Christopher C Rowe; Paul Maruff; Victor L Villemagne; Olivier Salvado; Ashley I Bush
Journal:  Brain       Date:  2017-08-01       Impact factor: 13.501

Review 5.  Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.

Authors:  Abdel A Belaidi; Ashley I Bush
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

6.  Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry.

Authors:  Dominic J Hare; Alexandra Grubman; Timothy M Ryan; Amber Lothian; Jeffrey R Liddell; Rudolf Grimm; Toshiaki Matsuda; Philip A Doble; Robert A Cherny; Ashley I Bush; Anthony R White; Colin L Masters; Blaine R Roberts
Journal:  Metallomics       Date:  2013-10-17       Impact factor: 4.526

7.  Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein.

Authors:  Scott Ayton; Peng Lei; Dominic J Hare; James A Duce; Jessica L George; Paul A Adlard; Catriona McLean; Jack T Rogers; Robert A Cherny; David I Finkelstein; Ashley I Bush
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

8.  Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes.

Authors:  L Zecca; M Gallorini; V Schünemann; A X Trautwein; M Gerlach; P Riederer; P Vezzoni; D Tampellini
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

9.  β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin.

Authors:  Bruce X Wong; Andrew Tsatsanis; Linh Q Lim; Paul A Adlard; Ashley I Bush; James A Duce
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

10.  A delicate balance: Iron metabolism and diseases of the brain.

Authors:  Dominic Hare; Scott Ayton; Ashley Bush; Peng Lei
Journal:  Front Aging Neurosci       Date:  2013-07-18       Impact factor: 5.750

View more
  25 in total

1.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

2.  APPealing for a role in cellular iron efflux.

Authors:  Debomoy K Lahiri; Bryan Maloney; Ruizhi Wang
Journal:  J Biol Chem       Date:  2019-06-14       Impact factor: 5.157

Review 3.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

4.  Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy.

Authors:  Ashley I Bush; Scott Ayton; Abdel Ali Belaidi; Shashank Masaldan; Adam Southon; Pawel Kalinowski; Karla Acevedo; Ambili T Appukuttan; Stuart Portbury; Peng Lei; Puja Agarwal; Sue E Leurgans; Julie Schneider; Marcus Conrad
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

5.  Tip60/Kat5 may be a novel candidate histone acetyltransferase for the regulation of liver iron localization via acetylation.

Authors:  Nurdan Gönül Baltacı; Emine Toraman; Mesut Akyüz; Şeyda Nur Kalın; Harun Budak
Journal:  Biometals       Date:  2022-08-20       Impact factor: 3.378

Review 6.  Rhythms of life: circadian disruption and brain disorders across the lifespan.

Authors:  Ryan W Logan; Colleen A McClung
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

7.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

8.  Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort.

Authors:  Elizabeth Vance; Josue D Gonzalez Murcia; Justin B Miller; Lyndsay Staley; Paul K Crane; Shubhabrata Mukherjee; John S K Kauwe
Journal:  Neurobiol Aging       Date:  2020-02-12       Impact factor: 4.673

Review 9.  Opioid Modulation of Neuronal Iron and Potential Contributions to NeuroHIV.

Authors:  Bradley Nash; Elena Irollo; Renato Brandimarti; Olimpia Meucci
Journal:  Methods Mol Biol       Date:  2021

Review 10.  Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.

Authors:  Andrew Gleason; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2020-10-27       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.